SPACA9
gene geneOn this page
Also known as Mast
Summary
SPACA9 (sperm acrosome associated 9, HGNC:1367) is a protein-coding gene on chromosome 9q34.13, encoding Sperm acrosome-associated protein 9 (Q96E40). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) of multiciliated respiratory cells and the distal singlet microtubules of monoflagellated spermatozoa.
Enables microtubule binding activity. Involved in axoneme assembly. Located in axonemal microtubule.
Source: NCBI Gene 11092 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_001316897
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:1367 |
| Approved symbol | SPACA9 |
| Name | sperm acrosome associated 9 |
| Location | 9q34.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Mast |
| Ensembl gene | ENSG00000165698 |
| Ensembl biotype | protein_coding |
| OMIM | 618552 |
| Entrez | 11092 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 protein_coding
ENST00000350499, ENST00000356311, ENST00000372136, ENST00000855798, ENST00000944246, ENST00000944247
RefSeq mRNA: 4 — MANE Select: NM_001316897
NM_001316897, NM_001316898, NM_001316900, NM_018956
CCDS: CCDS6955, CCDS83434
Canonical transcript exons
ENST00000356311 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001095608 | 132887369 | 132887571 |
| ENSE00001095610 | 132883911 | 132884091 |
| ENSE00001412168 | 132878898 | 132879014 |
| ENSE00003848759 | 132888290 | 132890030 |
Expression profiles
Bgee: expression breadth ubiquitous, 239 present calls, max score 97.69.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.1289 / max 284.6346, expressed in 1729 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 99171 | 4.9386 | 1656 |
| 99172 | 2.6477 | 1411 |
| 99173 | 1.4769 | 637 |
| 99174 | 0.0657 | 23 |
Top tissues by expression
275 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 97.69 | gold quality |
| right testis | UBERON:0004534 | 97.55 | gold quality |
| right uterine tube | UBERON:0001302 | 95.65 | gold quality |
| testis | UBERON:0000473 | 94.55 | gold quality |
| sperm | CL:0000019 | 92.91 | gold quality |
| male germ cell | CL:0000015 | 91.26 | gold quality |
| adult organism | UBERON:0007023 | 90.84 | gold quality |
| bronchial epithelial cell | CL:0002328 | 90.64 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 90.56 | gold quality |
| corpus epididymis | UBERON:0004359 | 90.50 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 89.36 | gold quality |
| bronchus | UBERON:0002185 | 88.29 | gold quality |
| parotid gland | UBERON:0001831 | 87.24 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 84.80 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.16 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 83.40 | gold quality |
| cingulate cortex | UBERON:0003027 | 83.35 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 83.27 | gold quality |
| nucleus accumbens | UBERON:0001882 | 83.17 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 83.11 | gold quality |
| prefrontal cortex | UBERON:0000451 | 83.03 | gold quality |
| caudate nucleus | UBERON:0001873 | 82.77 | gold quality |
| right frontal lobe | UBERON:0002810 | 82.56 | gold quality |
| hypothalamus | UBERON:0001898 | 82.27 | gold quality |
| spinal cord | UBERON:0002240 | 82.24 | gold quality |
| thyroid gland | UBERON:0002046 | 82.20 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.82 | gold quality |
| amygdala | UBERON:0001876 | 81.59 | gold quality |
| cranial nerve II | UBERON:0000941 | 81.28 | gold quality |
| adenohypophysis | UBERON:0002196 | 80.96 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.34 |
| E-MTAB-4850 | no | 39.05 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- SPACA9 is a lumenal protein of human ciliary singlet and doublet microtubules. (PMID:36191189)
- Loss of Tumor Suppressor C9orf9 Promotes Metastasis in Colorectal Cancer. (PMID:36830681)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | spaca9 | ENSDARG00000068130 |
| mus_musculus | Spaca9 | ENSMUSG00000026809 |
| rattus_norvegicus | Spaca9 | ENSRNOG00000012697 |
Protein
Protein identifiers
Sperm acrosome-associated protein 9 — Q96E40 (reviewed: Q96E40)
All UniProt accessions (1): Q96E40
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) of multiciliated respiratory cells and the distal singlet microtubules of monoflagellated spermatozoa. Forms an extensive interaction network cross-linking the lumen of axonemal doublet microtubules.
Subunit / interactions. Microtubule inner protein component of sperm flagellar doublet microtubules. Interacts with CABP1 and CALR. Interacts with INCA1. Interacts with microtubules.
Subcellular location. Cytoplasm. Cytoplasmic vesicle. Secretory vesicle. Acrosome. Cytoskeleton. Cilium basal body. Flagellum axoneme. Cilium axoneme. Nucleus.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96E40-1 | 1 | yes |
| Q96E40-2 | 2 |
RefSeq proteins (4): NP_001303826, NP_001303827, NP_001303829, NP_061829 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027818 | SPACA9 | Family |
Pfam: PF15120
UniProt features (7 total): site 2, splice variant 2, chain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7UNG | ELECTRON MICROSCOPY | 3.6 |
| 8J07 | ELECTRON MICROSCOPY | 4.1 |
| 7UN1 | ELECTRON MICROSCOPY | 6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96E40-F1 | 80.92 | 0.68 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (2): 117 (essential for interaction with inca1); 119 (essential for interaction with inca1)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 139 (showing top):
GOCC_SECRETORY_GRANULE, MEF2_02, GOCC_MICROTUBULE_ORGANIZING_CENTER, NKX61_01, GOBP_CILIUM_ORGANIZATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_ORGANELLE_ASSEMBLY, GNF2_CCNA1, GOBP_MICROTUBULE_BUNDLE_FORMATION, RYTTCCTG_ETS2_B, CDPCR3HD_01, GOBP_CELL_PROJECTION_ORGANIZATION, MODULE_48, GOBP_AXONEME_ASSEMBLY
GO Biological Process (2): flagellated sperm motility (GO:0030317), axoneme assembly (GO:0035082)
GO Molecular Function (3): microtubule binding (GO:0008017), calcium-dependent protein binding (GO:0048306), protein binding (GO:0005515)
GO Cellular Component (15): acrosomal vesicle (GO:0001669), nucleus (GO:0005634), axonemal microtubule (GO:0005879), cytoplasmic microtubule (GO:0005881), axoneme (GO:0005930), ciliary basal body (GO:0036064), sperm flagellum (GO:0036126), ciliary base (GO:0097546), axonemal microtubule doublet inner sheath (GO:0160110), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cilium (GO:0005929), cytoplasmic vesicle (GO:0031410), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 5 |
| cilium | 3 |
| cytoplasm | 2 |
| microtubule | 2 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| microtubule bundle formation | 1 |
| cellular component assembly | 1 |
| cilium assembly | 1 |
| tubulin binding | 1 |
| calcium ion binding | 1 |
| protein binding | 1 |
| binding | 1 |
| secretory granule | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasmic microtubule | 1 |
| axoneme | 1 |
| cytoskeleton | 1 |
| ciliary plasm | 1 |
| microtubule organizing center | 1 |
| 9+2 motile cilium | 1 |
| ciliary transition zone | 1 |
| ciliary transition fiber | 1 |
| axonemal doublet microtubule | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
408 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPACA9 | SPACA7 | Q96KW9 | 604 |
| SPACA9 | FAM209A | Q5JX71 | 562 |
| SPACA9 | SERPINE3 | A8MV23 | 558 |
| SPACA9 | ANKRD29 | Q8N6D5 | 541 |
| SPACA9 | FAM124A | Q86V42 | 482 |
| SPACA9 | CFAP210 | Q0VFZ6 | 479 |
| SPACA9 | CFAP77 | Q6ZQR2 | 474 |
| SPACA9 | AK8 | Q96MA6 | 450 |
| SPACA9 | CCDC17 | Q96LX7 | 447 |
| SPACA9 | TMEM31 | Q5JXX7 | 445 |
| SPACA9 | IZUMO4 | Q1ZYL8 | 434 |
| SPACA9 | GLIPR1L1 | Q6UWM5 | 424 |
| SPACA9 | OLA1 | Q9NTK5 | 408 |
| SPACA9 | SPACA4 | Q8TDM5 | 402 |
| SPACA9 | GTF3C5 | Q9Y5Q8 | 401 |
IntAct
34 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPACA9 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| SPACA9 | KRTAP10-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | SPACA9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPACA9 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | SPACA9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EXOC5 | SPACA9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-8 | SPACA9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPACA9 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPACA9 | EXOC5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-1 | SPACA9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EFEMP2 | SPACA9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPACA9 | H3-4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TSC22D1 | SPACA9 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SPACA9 | RIOX2 | psi-mi:“MI:0914”(association) | 0.350 |
| TEX101 | GGT3P | psi-mi:“MI:0914”(association) | 0.350 |
| SPACA9 | ODR4 | psi-mi:“MI:0914”(association) | 0.350 |
| EBAG9 | psi-mi:“MI:0914”(association) | 0.350 | |
| SPACA9 | KRTAP1-1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPACA9 | EFEMP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (25): C9orf9 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP10-8 (Two-hybrid), KRTAP10-3 (Two-hybrid), MUCL1 (Affinity Capture-MS), NXN (Affinity Capture-MS), MINA (Affinity Capture-MS), MINA (Affinity Capture-MS), MUCL1 (Affinity Capture-MS), C9orf9 (Affinity Capture-MS), C9orf9 (Two-hybrid), EFEMP2 (Two-hybrid), KRTAP1-1 (Two-hybrid)
ESM2 similar proteins: A0A1B0GVH6, A0A1L8FZ84, A0A2K1J5A5, A0A2K1JJ00, A4IGV6, B3DHS1, O94243, O95561, P03209, P04605, P05909, P17759, P18098, P22051, P24109, P24433, P32845, Q00039, Q03233, Q03937, Q06616, Q09824, Q0VCV7, Q12418, Q13352, Q19541, Q1T763, Q3KPS4, Q5R5R7, Q5RD08, Q5XHY8, Q5XIU7, Q6AXY9, Q6DFB0, Q703I1, Q759B7, Q8N9R6, Q8TAL5, Q8WWF3, Q95JJ2
Diamond homologs: Q4V8P4, Q7TPM5, Q96E40
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 16 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 5 | 23.2× | 3e-05 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1100 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:132879013:GG:G | donor_gain | 1.0000 |
| 9:132879014:GG:G | donor_gain | 1.0000 |
| 9:132879023:GGA:G | donor_gain | 1.0000 |
| 9:132883906:CATA:C | acceptor_loss | 1.0000 |
| 9:132883908:T:G | acceptor_gain | 1.0000 |
| 9:132883908:TA:T | acceptor_loss | 1.0000 |
| 9:132883909:A:AG | acceptor_gain | 1.0000 |
| 9:132883909:A:G | acceptor_loss | 1.0000 |
| 9:132883910:G:GC | acceptor_gain | 1.0000 |
| 9:132883910:GA:G | acceptor_gain | 1.0000 |
| 9:132883910:GAT:G | acceptor_gain | 1.0000 |
| 9:132883910:GATT:G | acceptor_gain | 1.0000 |
| 9:132883910:GATTC:G | acceptor_gain | 1.0000 |
| 9:132884088:ACAGG:A | donor_loss | 1.0000 |
| 9:132884089:CAGGT:C | donor_loss | 1.0000 |
| 9:132884090:AGGT:A | donor_loss | 1.0000 |
| 9:132884091:GGT:G | donor_loss | 1.0000 |
| 9:132884092:GTGGG:G | donor_loss | 1.0000 |
| 9:132884093:T:G | donor_loss | 1.0000 |
| 9:132887567:GCAAA:G | donor_gain | 1.0000 |
| 9:132887568:CAAAG:C | donor_loss | 1.0000 |
| 9:132887570:AA:A | donor_gain | 1.0000 |
| 9:132887570:AAGTA:A | donor_loss | 1.0000 |
| 9:132887571:AG:A | donor_loss | 1.0000 |
| 9:132887572:G:GG | donor_gain | 1.0000 |
| 9:132887572:G:T | donor_loss | 1.0000 |
| 9:132887573:TAAGT:T | donor_loss | 1.0000 |
| 9:132888434:GCAC:G | donor_gain | 1.0000 |
| 9:132888438:G:GG | donor_gain | 1.0000 |
| 9:132888442:G:GG | donor_gain | 1.0000 |
AlphaMissense
1475 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:132888357:A:C | S139R | 0.998 |
| 9:132888359:C:A | S139R | 0.998 |
| 9:132888359:C:G | S139R | 0.998 |
| 9:132884020:T:C | F25L | 0.995 |
| 9:132884021:T:C | F25S | 0.995 |
| 9:132884022:C:A | F25L | 0.995 |
| 9:132884022:C:G | F25L | 0.995 |
| 9:132887429:T:C | F69L | 0.995 |
| 9:132887431:C:A | F69L | 0.995 |
| 9:132887431:C:G | F69L | 0.995 |
| 9:132887430:T:C | F69S | 0.994 |
| 9:132888393:T:A | W151R | 0.994 |
| 9:132888393:T:C | W151R | 0.994 |
| 9:132884046:G:C | R33S | 0.992 |
| 9:132884046:G:T | R33S | 0.992 |
| 9:132884000:T:C | F18S | 0.991 |
| 9:132887522:T:C | C100R | 0.990 |
| 9:132888355:T:A | V138D | 0.989 |
| 9:132888346:G:A | G135D | 0.988 |
| 9:132884030:C:A | A28D | 0.987 |
| 9:132884045:G:T | R33M | 0.987 |
| 9:132884045:G:C | R33T | 0.986 |
| 9:132888330:G:C | A130P | 0.986 |
| 9:132884033:T:C | L29P | 0.985 |
| 9:132887451:T:C | L76P | 0.985 |
| 9:132887430:T:G | F69C | 0.984 |
| 9:132888291:T:G | Y117D | 0.984 |
| 9:132888291:T:C | Y117H | 0.983 |
| 9:132888294:C:T | P118S | 0.983 |
| 9:132888316:T:C | L125P | 0.983 |
dbSNP variants (sampled 300 via entrez): RS1000177188 (9:132884932 G>A), RS1000229577 (9:132884718 G>GT), RS1000304673 (9:132878335 G>A,C), RS1000440912 (9:132889576 A>G,T), RS1000601599 (9:132884534 G>A,C), RS1000748398 (9:132889868 C>T), RS1000811466 (9:132890231 C>G), RS1001591535 (9:132878963 C>T), RS1001818163 (9:132881669 T>G), RS1001994189 (9:132890473 G>A), RS1002094927 (9:132885176 T>C), RS1002145719 (9:132885424 A>G), RS1002343322 (9:132890308 C>T), RS1002421194 (9:132880487 C>G,T), RS1002565286 (9:132888076 C>T)
Disease associations
OMIM: gene MIM:618552 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| Tunicamycin | increases expression | 2 |
| Valproic Acid | affects expression, increases methylation | 2 |
| afuresertib | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| bisphenol A | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| 4-aminophenylarsenoxide | affects binding, decreases reaction | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| MRK 003 | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| Arsenic Trioxide | affects binding, decreases reaction | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Rotenone | increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Thapsigargin | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.